Bio-Techne Corporation (TECH)
NASDAQ: TECH
· Real-Time Price · USD
47.89
-3.72 (-7.21%)
At close: May 14, 2025, 3:59 PM
47.52
-0.76%
After-hours: May 14, 2025, 07:47 PM EDT
Bio-Techne Revenue Breakdown
| Period Ending | Jun 30, 2024 | Jun 30, 2023 |
|---|---|---|
| Consumables Revenue | 928.18M | 917.73M |
| Consumables Revenue Growth | +1.14% | n/a |
| Instruments Revenue | 108.27M | 112.08M |
| Instruments Revenue Growth | -3.40% | n/a |
| Royalty Revenue | 23.34M | 21.1M |
| Royalty Revenue Growth | +10.64% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 151.27M | 121.45M | 119.16M | 101.9M | 107.5M | 115.67M | 105.33M | 86.75M | 99.24M | 93.01M | 99.38M | 96.63M | 89.27M | 100.69M | 86.17M | 86.64M | 82.6M | 83.12M | 72.6M | 57.22M | 66.32M | 68.03M | 69.01M | 68.74M | 64.97M | 63.6M | 67.05M | 65.29M | 53.28M | 63.77M | 58.29M | 47.2M | 48.11M | 55.66M | 46.26M | 38.04M | 35.22M | 34.59M | 33.04M | 30.47M | 29.09M |
| Selling, General, and Administrative Revenue Growth | +24.55% | +1.92% | +16.94% | -5.22% | -7.06% | +9.81% | +21.41% | -12.58% | +6.70% | -6.41% | +2.84% | +8.25% | -11.35% | +16.85% | -0.54% | +4.90% | -0.63% | +14.49% | +26.87% | -13.71% | -2.52% | -1.42% | +0.40% | +5.80% | +2.15% | -5.14% | +2.70% | +22.52% | -16.45% | +9.41% | +23.50% | -1.89% | -13.56% | +20.30% | +21.63% | +8.01% | +1.83% | +4.68% | +8.42% | +4.76% | n/a |
| Research and Development Revenue | 24.58M | 25.02M | 23.87M | 23.99M | 25.76M | 22.92M | 24M | 23.42M | 22.71M | 22.46M | 23.9M | 23.15M | 21.74M | 20.65M | 21.6M | 20.72M | 17.05M | 16.79M | 16.04M | 16.78M | 15.95M | 16.38M | 16.08M | 16.26M | 15.55M | 15.81M | 14.79M | 13.98M | 13.89M | 13.91M | 13.55M | 13.7M | 13.77M | 13.28M | 12.77M | 11.64M | 11.24M | 10.98M | 11.32M | 10.81M | 10.87M |
| Research and Development Revenue Growth | -1.75% | +4.81% | -0.50% | -6.88% | +12.41% | -4.51% | +2.48% | +3.10% | +1.13% | -6.04% | +3.26% | +6.47% | +5.29% | -4.40% | +4.24% | +21.52% | +1.57% | +4.66% | -4.40% | +5.17% | -2.61% | +1.89% | -1.12% | +4.55% | -1.64% | +6.92% | +5.79% | +0.63% | -0.14% | +2.68% | -1.09% | -0.54% | +3.69% | +4.04% | +9.64% | +3.54% | +2.44% | -3.05% | +4.71% | -0.48% | n/a |